SciClone Pharmaceuticals
Country
USA
Краткое название
SciClone Pharmaceuticals
Headquarters
950 Tower Lane Suite 900
Members of the board
Jon Saxe,
Independent Chairman of the Board
Friedhelm Blobel,
President, Chief Executive Officer, Director
Gary Titus,
Chief Financial Officer, Senior Vice President - Finance
Simon Li,
Director
Peter Barret,
Independent Director
Richard Hawkins,
Independent Director
Gregg Lapointe,
Independent Director
Ira Lawrence,
Independent Director
Categories medicine
Cardiology, Oncology, Infectious diseases
Stage of the project
Production
Disease
Viral hepatitis, Lung cancer, Hypertensive disease
Ticker
SCLN
Assets
464.7600
Technology
Vaccines, Devices, Technologies, Pharmaceuticals, Chemistry